Zobrazeno 1 - 10 of 23 pro vyhledávání: '"Stefania Cusenza"'
1
Akademický článek
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma
Autor: Valerio Gristina, Maria La Mantia, Antonio Galvano, Sofia Cutaia, Nadia Barraco, Marta Castiglia, Alessandro Perez, Marco Bono, Federica Iacono, Martina Greco, Katia Calcara, Valentina Calò, Sergio Rizzo, Lorena Incorvaia, Maria Chiara Lisanti, Giulia Santanelli, Delia Sardo, Sara Inguglia, Lavinia Insalaco, Luisa Castellana, Stefania Cusenza, Gianni Pantuso, Antonio Russo, Viviana Bazan
Publikováno v: Journal of Molecular Pathology, Vol 2, Iss 2, Pp 173-196 (2021)
The molecular pathways which promote lung cancer cell features have been broadly explored, leading to significant improvement in prognostic and diagnostic strategies. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have dram
Externí odkaz: https://doaj.org/article/073f09f41eb9496ab2daf6aa9c99d7c2
Zobrazit plný text záznamu
2
Akademický článek
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses
Autor: Valerio Gristina, Antonio Galvano, Luisa Castellana, Lavinia Insalaco, Stefania Cusenza, Giuseppa Graceffa, Federica Iacono, Nadia Barraco, Marta Castiglia, Alessandro Perez, Sergio Rizzo, Antonio Russo, Viviana Bazan
Publikováno v: Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: The addition of PD-L1 inhibitors to platinum-based chemotherapy (CT) has newly received United States Food and Drug Administration (FDA) approval in extensive stage-small cell lung cancer (ES-SCLC). PD-1 agents similarly improved survival
Externí odkaz: https://doaj.org/article/a40caf50846b4429829ea33b2d977320
Zobrazit plný text záznamu
3
Akademický článek
pathogenic variants in triple-negative luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients
Autor: Lorena Incorvaia, Daniele Fanale, Marco Bono, Valentina Calò, Alessia Fiorino, Chiara Brando, Lidia Rita Corsini, Sofia Cutaia, Daniela Cancelliere, Alessia Pivetti, Clarissa Filorizzo, Maria La Mantia, Nadia Barraco, Stefania Cusenza, Giuseppe Badalamenti, Antonio Russo, Viviana Bazan
Publikováno v: Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Background: Several available data suggest the association between specific molecular subtypes and BRCA1/2 mutational status. Previous investigations showed the association between BRCA1/2 pathogenic variants (PVs) in specific genomic regions and phe
Externí odkaz: https://doaj.org/article/e9cbd3a4ec0b4189919afc2b36594623
Zobrazit plný text záznamu
4
Akademický článek
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials
Autor: Antonio Galvano, Dalila Scaturro, Giuseppe Badalamenti, Lorena Incorvaia, Sergio Rizzo, Luisa Castellana, Stefania Cusenza, Sofia Cutaia, Daniele Santini, Fiorella Guadagni, Mario Roselli, Stefania Gori, Mario Adelfio Latteri, Viviana Bazan, Letizia Mauro Giulia, Antonio Russo
Publikováno v: Journal of Bone Oncology, Vol 18, Iss , Pp - (2019)
Hormonal therapies for receptor positive-breast and prostate cancer patients have shown clinical efficacy but also several side effects including osteoporosis, loss of bone mass and increased fracture risk. Denosumab represents an anti RANKL (recepto
Externí odkaz: https://doaj.org/article/161c435a51914811ab0735ace62178c6
Zobrazit plný text záznamu
5
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma
Autor: Martina Greco, Valentina Calò, Sergio Rizzo, Alessandro Perez, F. Iacono, Sara Inguglia, Stefania Cusenza, Gianni Pantuso, Delia Sardo, L. Insalaco, Lorena Incorvaia, Marta Castiglia, Marco Bono, Valerio Gristina, Antonio Galvano, Maria La Mantia, Katia Calcara, Antonio Russo, Giulia Santanelli, Maria Chiara Lisanti, L. Castellana, Sofia Cutaia, Nadia Barraco, V. Bazan
Publikováno v: Journal of Molecular Pathology, Vol 2, Iss 16, Pp 173-196 (2021)
The molecular pathways which promote lung cancer cell features have been broadly explored, leading to significant improvement in prognostic and diagnostic strategies. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have dram
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e177dcdbfd61283d644c869cbc01ebc
https://doi.org/10.3390/jmp2020016
Zobrazit plný text záznamu
6
Is there any room for PD-1 inhibitors in combination with platinum-based chemotherapy as frontline treatment of extensive-stage small cell lung cancer? A systematic review and meta-analysis with indirect comparisons among subgroups and landmark survival analyses
Autor: Antonio Russo, Stefania Cusenza, Giuseppa Graceffa, Sergio Rizzo, Marta Castiglia, L. Castellana, Antonio Galvano, L. Insalaco, Nadia Barraco, F. Iacono, Alessandro Perez, Viviana Bazan, Valerio Gristina
Publikováno v: Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Therapeutic Advances in Medical Oncology
Background: The addition of PD-L1 inhibitors to platinum-based chemotherapy (CT) has newly received United States Food and Drug Administration (FDA) approval in extensive stage-small cell lung cancer (ES-SCLC). PD-1 agents similarly improved survival
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b73261d3f9d41bc985f0d43859ecbdbf
https://doaj.org/article/a40caf50846b4429829ea33b2d977320
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje